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PCSK9 is suggestive of TICE activation. We conclude that 
in C57BL/6J mice plant stanol kinetics are fast, and affect 
intestinal and hepatic gene expression within 15 min post-
prandial after lymph-mediated uptake.
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Abstract The kinetics of plant stanol uptake and rout-
ing in 8-week-old C57BL/6J mice were determined after 
a plant stanol ester gavage. In addition, acute changes in 
intestinal and hepatic gene expression were investigated. 
Mice were fed a plant sterol/stanol poor diet from weaning. 
At the age of 8 weeks, they received an oral gavage con-
sisting of 0.25 mg cholesterol + 50 mg plant stanol esters 
dissolved in olive oil. Animals were euthanized at differ-
ent time points. In a second comparable set-up, mesenteric 
lymph-cannulated versus sham-operated mice received 
the same oral gavage, which was now deuterium labeled. 
Intestinal and hepatic sitostanol concentrations increased 
within 15 min post-gavage. This rapid hepatic appearance 
was absent in lymph-cannulated mice, suggesting a very 
fast lymph-mediated uptake. Hepatic mRNA expression of 
SREBP2 and its target genes rapidly decreased, whereas 
expression of LXR target genes increased. The intesti-
nal SREBP2 pathway was increased, whereas the expres-
sion of LXR target genes hardly changed. The fivefold 
and sixfold increased expression of intestinal LDLr and 
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TAG  Triacylglycerol
TICE  Transintestinal cholesterol 
excretion
Introduction
In humans, plant sterols and stanols lower intestinal choles-
terol absorption, thereby reducing serum low-density lipo-
protein cholesterol (LDL-C) concentrations up to 10 % at 
daily intakes of 2–2.5 g [1]. The exact mechanisms under-
lying this effect are unknown. Besides competition with 
cholesterol for incorporation into mixed micelles, which 
is necessary for intestinal cholesterol absorption [2], other 
mechanisms extending towards whole body sterol metabo-
lism have been suggested [3]. Within the enterocytes and 
hepatocytes, there are numerous proteins involved in the 
transport and metabolism of cholesterol and plant sterols/
stanols. For example, overexpression of the human gene 
encoding ATP-binding cassette transporter G5 and G8 
(ABCG5, ABCG8) in the liver and the small intestine of 
C57BL/6J × SJL F2 mice reduced intestinal cholesterol 
absorption and promoted biliary cholesterol secretion [4]. 
Although these cholesterol transporter genes are under 
control of the liver X receptor (LXR), plant sterol and 
stanol ester feeding increased fecal neutral sterol excre-
tion without changing intestinal LXR expression [5]. Fur-
thermore, intestinal expression of LXR target genes such 
as Niemann-Pick C1-Like protein 1 (NPC1L1), ABCA1, 
ABCG5, ABCG8 was not influenced after plant sterol or 
stanol intake [6]. 
Consumption of plant sterols or stanols might also 
interfere with intracellular sterol handling, i.e., the incor-
poration of cholesterol into chylomicrons. In this respect, 
Liang et al. [7] showed decreased mRNA expression of 
acetyl-coenzyme A acetyltransferase (ACAT2) and micro-
somal triglyceride transfer protein (MTTP) after sitos-
terol feeding in Golden Syrian hamsters. Also, basolateral 
apolipoprotein B (apoB) secretion by HepG2 and Caco2 
cells was decreased after incubation with plant sterols, sug-
gesting a reduced production of lipoproteins by these liver 
and intestinal cell lines [8]. Although not conclusive, these 
studies show that plant sterols and stanols affect intesti-
nal and hepatic sterol metabolism in vitro and in various 
animal models. For the animal data, the absence of con-
sistent effects may relate to the various amounts of plant 
sterols in the diets, resulting in different tissue and serum 
concentrations, which may affect pathways underlying 
the cholesterol-lowering effects of the added plant ster-
ols/stanols. Besides the potentially confounding effect of 
the background diet, it should also be acknowledged that 
metabolism in rodents is extremely fast in comparison to 
man. In this context, Igel and coworkers [9] showed earlier 
that in mice, intestinal uptake of dietary plant sterols was 
an extremely fast process, i.e., free plant sterols adminis-
tered into the stomach were already present in enterocytes 
15 min later. In other words, to study in vivo effects of 
plant sterols and stanols in mice, sampling must occur at 
short intervals immediately after administration. To gain 
more insight in the kinetics of plant sterol and stanol dis-
tribution, we used C56BL/6J mice, which were fed a plant-
sterol-poor and plant-stanol-poor diet from weaning. We 
were particularly interested to see whether the fast appear-
ance of plant sterols in the enterocytes was also visible in 
the liver. In addition, the acute effects of plant stanol esters 
on intestinal and hepatic expression of genes involved in 
lipid and lipoprotein metabolism were monitored from 0 to 
240 min post-gavage. Post-gavage changes in plant sterol 
and deuterated plant stanol concentrations were examined 
as well. 
In this study, we show that an acute bolus of dietary 
deuterium labeled sitostanol provided as sitostanol oleate 
appeared already after 15 min in the liver. This rapid 
hepatic appearance was absent in lymph-cannulated mice, 
suggesting a very fast lymph-mediated uptake, possible via 
pre-formed available chylomicrons. Also, the expression 
profiles of genes involved in hepatic and intestinal lipid and 
lipoprotein metabolism changed rapidly after the gavage. 
Interestingly, effects on gene expression in liver and intes-
tine were in the opposite direction.
Materials and Methods
Study 1: Animals, Diet and Experimental Design
Female C57BL/6J pups (F0) were fed a plant-sterol-poor 
and plant-stanol-poor diet from weaning, and were used 
for breeding at the age of 8 weeks. The newborn pups (F1) 
were fed the same plant-sterol-poor and plant-stanol-poor 
diet and housed in a light-controlled and temperature-
controlled facility with free access to water. At the age of 
8 weeks, the mice (10 males/11 females) were given an 
oral gavage consisting of unesterified cholesterol (0.25 mg) 
(Sigma, St. Louis, Mo) and plant stanols (50 mg), which 
were provided as their fatty acid esters, dissolved in 500 μl 
refined plant-sterol-poor olive oil. Their regular plant-
sterol-poor food was removed from the cages 2 h before the 
start of the gavage to bring the mice into “fasting” condi-
tion. The stanol ester mixture used was prepared by RAI-
SIO Nutrition Ltd. and was composed of 70 % sitostanol 
and 30 % campestanol (Benecol Liquid, Raisio, Finland). 
Plant stanols were esterified with a fatty acid blend con-
taining 80 % linoleic acid, 15 % oleic acid and 5 % stearic 
and palmitic acids to produce fat-soluble plant stanol 
esters. All mice were injected with Temgesic (0.1 mg/kg) 
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[Schering-Plough, Reckitt Benckiser Healthcare (UK) 
Limited] subcutaneously 30 min before the gavage for pain 
relief. At seven different time points post-gavage (T = 0, 
15, 30, 60, 120, 180 and 240 min), mice were anesthe-
tized with isoflurane (1–2 %), directly followed by blood 
and tissue collection. Blood was taken via heart puncture at 
the time the mice were sacrificed. There were no repeated 
blood samples from the same animal, which means that 
each time point on a curve is composed of data from differ-
ent animals. The experiment was approved by the Ethical 
Committee for animal testing of Maastricht University, the 
Netherlands (project number 2009-129).
Study 2: Animals, Diet and Experimental Design
For this experiment, 35 male C57BL/6J mice were fed a 
plant-sterol-poor and plant-stanol-poor diet from wean-
ing, as described for study 1. At the age of 8 weeks, mice 
were anesthetized and the ductus lymphaticus thoracicus 
was cannulated proximal from the cisternae magnum via an 
abdominal approach. The mice in the control group were 
subjected to a sham operation, leaving the lymph circula-
tion intact. Immediately after surgery, they received the 
same gavages as used in study 1. The only difference was 
that we now used d4-plant stanols (50 mg), which were 
esterified with oleic acid and d6-cholesterol (0.25 mg). A 
hydrogenation reaction was used to reduce stigmasterol 
to d4-plant stanols [10]. The esterification of d4-plant 
stanols was performed by RAISIO Nutrition Ltd, Finland. 
The plant stanol blend contained 90 % d4-sitostanol, 8 % 
d4-campestanol and 2 % non-labeled stigmasterol and 
brassicasterol. Using the deuterated plant stanols and cho-
lesterol enabled us to specifically follow the plant stanols 
and cholesterol from the gavage into circulation and the tis-
sues over time. The mice remained under anesthesia until 
they were sacrificed at six different time points post-gav-
age. This experiment was approved by the Ethical Commit-
tee on animal testing of Groningen University, the Nether-
lands (project number 5356D).
Sample Collection
In both studies, blood was collected by cardiac puncture 
into EDTA tubes 2 h after abstaining from food. Plasma 
was separated from whole blood by centrifugation at 
1000×g and stored at −80 °C. After sacrificing, the liver 
was removed, rinsed with phosphate buffered saline (PBS), 
and stored for mRNA expression analysis and measurement 
of plant sterol and stanol concentrations. The intestines 
were removed, carefully rinsed after a midline incision 
and divided into four segments: the duodenum, jejunum, 
ileum and colon. Next, each segment was further divided 
into smaller parts. The first part of the three small intestinal 
segments was used for mRNA analysis. These samples 
were immediately frozen in liquid nitrogen. In contrast, the 
second part of the intestinal segments, which was used to 
determine the sterol and stanol concentrations, was scraped 
before freezing in order to obtain an enterocyte-rich sam-
ple. All samples were stored at −80 °C.
Serum and Tissue Concentration of Sterols and Stanols
Hepatic, intestinal and plasma plant sterol (sitosterol and 
campesterol), plant stanol (sitostanol and campestanol), 
cholestanol and cholesterol precursor (lathosterol and des-
mosterol) concentrations were analyzed by gas–liquid chro-
matography–mass spectrometry (GC–MS), as described 
previously [11]. D4-plant stanols and d6-cholesterol were 
measured as described by Lütjohann et al. [9] and Sudhop 
et al. [12]. All samples from the same animal were always 
analyzed in the same run.
RNA Preparation and Real‑Time RT‑PCR
Total RNA was isolated from the livers, the duodenum, 
the jejunum and the ileum. After grinding, the lysate was 
homogenized in RLT buffer. RNA purification was con-
ducted using the RNeasy mini kit (Qiagen, The Nether-
lands). Reverse transcription was performed with 350 ng 
total RNA as described [13]. To 2 μl cDNA, 1 μl primer of 
the gene of interest and 1 μl primer of the household gene 
were added (Table 1). The PCR mixture also consisted of 
6 μl water and 10 μl mastermix (Applied Biosystems). 
The cDNA was amplified for 40 cycles. The probes from 
the genes of interest were FAM labeled at the 5′ end. All 
data was normalized to hypoxanthine phosphoribosyltrans-
ferase 1 (HPRT1) (VIC labeled/MGB Probe, Primer Lim-
ited; Gibco, Life Technologies). Thus, the expression of the 
Table 1  Genes of interest and their specific assay on demand
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gene of interest and the household gene, i.e., vic-labeled 
HPRT1, was measured in duplicate in the same run. Next, 
the average cycle threshold (Ct) was calculated for the gene 
of interest and for the household gene. Based on the differ-
ence between both Ct values, the comparative was calcu-
lated. The comparative of the mice sacrificed at time point 
0 was set at 1. The comparative of all the other time points 
was normalized to the control comparative of time point 0.
Results
Intestinal Cholesterol and Plant Stanol Concentrations
During the 240-min post-gavage period in study 1, there 
was a clear response in transit time of plant stanols within 
the scraped enterocytes from proximal to distal along the 
gastrointestinal tract. As expected, the increase in sitostanol 
became apparent first in the duodenum, followed by the 
jejunum, ileum, and finally the colon. Results for abso-
lute (μg/mg wet tissue; Figs. 1, 2a) as well as cholesterol-
standardized (Figs. 1, 2a′) levels were comparable. The 
same patterns were observed for campestanol, but were less 
pronounced, which could be explained by the composition 
of the gavage (Fig. 1b, b′). There was a remarkably strong 
increase in both sitostanol as well as campestanol con-
centrations in the ileum after 2 h. As expected, the uptake 
at the apical side between the lymph-cannulated and the 
sham-operated mice (supporting information in Fig. 1a 
and b) was comparable. Also, the pattern of d4-sitostanol/
d6-cholesterol was comparable to that of d4-campestanol/
d6-cholesterol, which was again less pronounced. Although 
the gavage also contained a small amount of cholesterol, 
the total cellular cholesterol concentrations in the scraped 
enterocytes decreased slightly over time (Fig. 1c). How-
ever, concentrations of the gavage-derived d6-cholesterol 
within enterocytes increased over time (study 2; Fig. 2c, d).
Intestinal Expression Profile of Genes Involved in Sterol 
Metabolism
The intestinal mRNA expression of sterol regulatory ele-
ment binding protein 2 (SREBP2) and its target genes, 
3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA 
reductase), the low-density lipoprotein receptor (LDLr) 
and proprotein convertase subtilisin/kexin type 9 (PCSK9), 
were clearly upregulated (Fig. 3a) during the post-gav-
age period. However, the increase in mRNA expression 
of HMG-CoA reductase did not result in an increase in 
lathosterol and desmosterol concentrations (Fig. 4a). There 
was no clear consistent change in the duodenal expression 
profiles of LXRα and its target genes ABCG5, ABCG8 
and ABCA1 throughout the post-gavage period (Fig. 3b). 
Finally, both intestinal apoB and MTTP expression slightly, 
but gradually, increased over time for 3 h following the 
gavage (Fig. 3c).
Serum and Hepatic Cholesterol and Plant Stanol 
Concentrations Over Time
In study 1, serum sitostanol and campestanol concentra-
tions clearly increased during the hours following the oral 
gavage. This increase in serum concentrations started from 
30 to 60 min post-gavage (Fig. 5) and continued over the 
following hours. Surprisingly, hepatic sitostanol concen-
trations were already increased after 15 min (Fig. 6a), i.e., 
even before the increase in serum sitostanol concentrations 
became evident. After this first rapid appearance, sito-
stanol concentrations decreased and increased again after 
120 min. Hepatic campestanol concentrations followed the 
same pattern, but like for the enterocytes, changes were less 
pronounced.
The intriguing question is now via which route the plant 
stanols reached the liver after just 15 min. Interestingly, 
this very rapid hepatic appearance of the plant stanols was 
absent in the lymph-cannulated mice in study 2 (Fig. 6b), 
whereas it was again clearly visible in the sham-operated 
mice (Fig. 6c). From the data in study 2, it is evident that 
the hepatic plant stanols were derived from the gavage, 
since the gavage contained d4-plant stanols that could be 
detected in the liver. All changes in serum and hepatic plant 
stanol concentrations occurred without changing hepatic 
and serum cholesterol concentrations (supporting infor-
mation, Fig. 2a and b). Finally, we were not able to detect 
d6-cholesterol in the liver in the post-gavage period.
Hepatic Expression Profile of Genes Involved in Sterol 
Metabolism
In the liver, mRNA expression levels of SREBP2 and its 
target genes HMG-CoA reductase, the LDLr and PCSK9 
were all very rapidly down-regulated, after only 15 min 
(Fig. 7a). The hepatic concentration of lathosterol and des-
mosterol remained practically stable (Fig. 4b). In contrast 
to the downregulation of the SREBP2 pathway, hepatic 
expression profiles of LXRα and its target genes ABCG5 
and ABCG8 were already upregulated again, starting after 
15 min (Fig. 7b). Finally, mRNA levels of apoB and MTTP 
were immediately downregulated post-gavage (Fig. 7c).
Serum, Hepatic and Intestinal Cholestanol 
Concentrations Over Time
The ratio of cholestanol to cholesterol can be used to esti-
mate intestinal cholesterol absorption, because this marker 
is independent of the amount of plant sterols in the diet. 
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However, the use of cholestanol as a marker for cardiovas-
cular disease (CVD) risk is still controversial [14, 15]. We 
observed that the cholestanol curve in the serum (Fig. 8a) 
and in the duodenum (Fig. 8c) followed more or less the 
same pattern as the cholesterol curve.
Discussion
In this study, we show that in C57BL/6J wild-type mice, 
hepatic sitostanol and campestanol concentrations 
increased after 15 min following an oral gavage with 
(deuterated) plant stanol esters and cholesterol. This rapid 
hepatic appearance was absent in lymph-cannulated mice. 
Therefore, our data suggest that plant stanols can be taken 
up via a very fast lymph-mediated route, possibly via avail-
able preformed intestinal chylomicrons. Interestingly, 
changes in serum plant stanols lagged behind and became 
evident after 30–60 min. In the intestine, the SREBP2 
pathway was activated, whereas expression of LXRα and 
its target genes remained practically unchanged during the 
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Fig. 1  Study 1: time kinetics of sitostanol (a, a′), campestanol (b, b′) and cholesterol (c) levels in the intestinal tissue at different time points 
expressed as absolute value and as a ratio to cholesterol. Values are expressed as means (n = 2 or 3 each)
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PCSK9 expression was especially pronounced. Surpris-
ingly, changes in hepatic gene expression were opposite to 
those in the intestine. It should be noticed that these acute 
effects after a one-time single dose of plant stanol esters 
are different from those observed after longer-term intake 
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Fig. 2  Study 2: time kinetics of d4-sitostanol levels in intestinal tis-
sue of lymph-cannulated mice (a, a′) and of sham operated mice (b, 
b′) at different time points. Results are expressed as absolute concen-
tration and standardized for cholesterol. Each time point represents 
the mean of two or three animals. Time kinetics of d6-cholesterol (c) 
and cholesterol (c′) concentrations of lymph-cannulated mice and of 
sham-operated mice (d, d′) are shown in panel c and c′, and d and d′, 
respectively
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shown earlier an increased LDLr expression in peripheral 
blood mononuclear cells—which correlate positively to 
that in the liver [17]—after 8 weeksof plant stanol ester 
consumption [18]. Questions that are not answered by our 
studies are: (1) how do plant stanols reach the liver so rap-
idly after intake in a lymph-dependent way without a clear 
increase in serum concentrations; (2) do the plant stanols 
reach the liver in free or esterified form; and (3) does the 
acute change in hepatic plant stanol concentrations affect 
liver function?
As expected, there was a clear response in transit time of 
plant stanols within the enterocytes from proximal to dis-
tal along the gastrointestinal tract. This pattern was highly 
consistent and might relate to the fact that we fed the mice 
plant-sterol-poor diets from weaning to start the oral gav-
age with very low background plant sterol concentrations 
in serum as well as in tissues. In Table 2, we compared 
serum and tissue plant sterol concentrations in three differ-
ent studies using diets containing different plant sterol con-
tents. It is evident that lower plant sterol contents result in 
lower concentrations in various tissues. Therefore, it could 
be argued that differences in dietary plant sterol content 
might be a main reason for the large inconsistency between 
these studies. As shown in Fig. 1, in our hands, when using 
the plant-sterol-poor diets preceding the experimental day, 
15 min after the oral gavage, the sitostanol concentration 
started to increase in the proximal parts of the small intes-
tine. This is in agreement with observations from Igel and 
colleagues [9], who also detected deuterated sterols and 
stanols in the small intestinal wall 15 min after administra-
tion via a stomach tube, indicating that the uptake in the 
enterocytes is a rapid process in mice. Unexpectedly, plant 
stanol concentrations strongly increased in the ileum 2-h 
post-gavage.
This can be explained by the fact that the proximal part 
of the small intestine is the major site of chylomicron for-
mation and secretion, resulting in fast disappearance of 
plant stanols within the enterocyte of the duodenum and 
jejunum. In the more distal parts, chylomicron synthe-
sis is less, resulting in a transient accumulation of plant 
stanols [19] that fades away when ABCG5/ABCG8 activity 
increases [20].
In this study, we have shown that within the same time 
frame, plant stanol concentrations were also strongly ele-
vated in the liver, suggesting that plant stanol uptake and 
distribution is even faster than indicated by Igel et al. [9]. 
This extremely rapid hepatic appearance of sitostanol was 
unexpected, since it suggests that it only takes 15 min for 
the plant stanol esters to be digested and absorbed into the 
enterocytes, incorporated into chylomicrons, secreted into 
the lymph, and removed by the liver after entering the circu-
lation. We therefore propose that this very fast lymph-medi-
ated uptake should be facilitated via available preformed 
intestinal chylomicrons. Coppack et al. [21] described ear-
lier the possibility of releasing such chylomicrons follow-
ing ingestion of carbohydrate as well as mixed meals. Sur-
prisingly, there was no clear change in serum plant stanol 
or cholesterol concentrations preceding the hepatic appear-
ance at this early time point. It cannot be excluded that 
the enrichment of plant stanols in serum was too low to be 
detected at this stage due to a strong dilution. If true, this 
dilution must have been lower in the liver, making detec-
tion possible. The second, larger increase in hepatic plant 
stanol concentrations after 120 min might be explained by 
the uptake of chylomicron remnants by the liver. Theoreti-
cally, it is possible to explain this early increase in hepatic 
concentrations by postulating that plant stanols not only 
reach the liver via the “normal” chylomicron route, i.e., 
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Fig. 3  Study 1: changes in the expression profile of genes involved 
in the sterol metabolism in the duodenum. Values are expressed as 
means (n = 2 or 3 each)
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independent of chylomicron incorporation. Therefore, a sec-
ond study was performed to specifically address the route 
of entrance into the liver. In that study, we found that the 
rapid appearance of d4-plant stanols in the liver was absent 
in the lymph-cannulated mice. However, the uptake into the 
enterocytes was comparable between the lymph-cannulated 
and the sham-operated mice. Therefore, we must conclude 
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Fig. 4  Study 1: time kinetics of lathosterol and desmosterol levels in the duodenum (a, a′) and in the liver (b, b′) at different time points. 
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Fig. 5  Study 1: time kinetics of sitostanol and campestanol levels in the serum at different time points expressed as an absolute value and as a 
ratio to cholesterol. Values are expressed as means (n = 2 or 3 each)
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lymph-dependent. Interestingly, we were not able to detect 
d6-cholesterol in the liver within this short time frame, sug-
gesting that the hepatic appearance was specific for plant 
stanols. However, it could also be possible that the detection 
limit for d6-cholesterol was too low due to a strong dilution. 
In line with the observed reduced post-gavage cholesterol 
content of the scraped enterocytes in the duodenum, the 
expression of SREBP2 [22] and its target genes increased. 
Remarkably, the hepatic SREBP2 pathway was downregu-
lated. Whether this will affect metabolism is not known, as 
changes in mRNA expression are not always translated into 
changes in protein expression and activity. Therefore, we 
Fig. 6  Study 1: time kinetics 
of sitostanol and campestanol 
levels in the liver at different 
time points expressed as μg/
mg cholesterol (a). Study 2: 
time kinetics of D4-sitostanol, 
sitostanol, D4-campestanol and 
campestanol levels in the liver 
of lymph-cannulated mice (b) 
and in the liver of sham oper-
ated mice (c) at different time 
points. Values are expressed as 
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can only speculate why gene expression in these two tissues 
differed. In the intestine, intracellular cholesterol concentra-
tions post-gavage decreased, which might have activated the 
SREBP2 pathway. In the liver, the expression of LXR target 
genes ABCG5 and ABCG8, both involved in sterol efflux, 
was increased. The question remains whether the increased 
hepatic LXR expression can be explained by an effect 
of changes in intracellular cholesterol concentrations, or 
maybe via a direct effect of sitostanol. In this respect, both 
intestine and liver showed a rapid increase in sitostanol con-
centrations. Therefore, it is not likely that sitostanol itself 
will be responsible for the changes in gene expression. 
There might, however, be an alternative explanation. 
Spann et al. [23] recently showed that desmosterol was an 
important regulator in LXR activation in macrophages. We 
observed that desmosterol concentrations in the intestines 
were severely reduced by 15 min post-gavage, whereas 
those in the liver remained stable. In this respect, the large 
difference in absolute desmosterol concentrations between 
liver and intestine was remarkable. Therefore, it could be 
speculated that the differences in desmosterol concentra-
tions might have influenced tissue-specific LXR expres-
sion. However, It should be noticed that there was a time 
delay of several hours between the decrease in intestinal 
desmosterol concentrations and the changes in the expres-
sion profile of LXR. Finally, we found a decrease in the 
hepatic expression profile of MTTP and apoB, suggesting 
a reduced hepatic lipoprotein production, which is in line 
with earlier cell [8] and human studies [24].
The fivefold increased intestinal LDLr expression is 
suggestive for an enhanced clearance of cholesterol via 
the enterocytes. Le May et al. [25] showed that LDL pro-
vides cholesterol to the intestine for transintestinal cho-
lesterol excretion (TICE), which contributes up to 33 % 
of total fecal sterol loss in mice. Recently, Davidson and 
colleagues [26] also demonstrated a role for LDL particles 
in the delivery of cholesterol for TICE. Moreover, Bru-
fau et al. [27] earlier showed an increase in TICE activity 
after plant sterol intake. Therefore, it may be possible that 
the increased intestinal LDLr expression, observed in our 
study, contributes to plant-stanol-induced TICE activation. 
Recently, a role for not only intestinal LDLr expression, 
but also for PCSK9, was suggested in TICE [25]. Interest-
ingly, PCSK9 was the strongest upregulated gene we evalu-
ated in our study. Preclinical [28] as well as clinical studies 
[29] indicate that blocking PCSK9, thereby increasing the 
number of available LDL receptors, is an attractive route 
to lower LDL-C levels. More research is, however, needed 
to unravel the role of PCSK9 after consumption of plant 
stanols, especially in humans. Finally, if activation of TICE 
by plant stanols, thereby increasing the clearance of cho-
lesterol through intestinal LDLr upregulation and neutral 
sterol secretion into the intestinal lumen, contributes to the 
mechanism behind the LDL-C reductions, this may also 
explain why no clear reductions on chylomicron formation 
in humans are observed after plant stanol ester consump-
tion [30, 31]. In other words, it is possible that increased 
secretion and reduced intestinal cholesterol absorption 
explain the cholesterol-lowering activity of plant stanols. 
However, the suggested mechanism via TICE needs to be 
further elucidated. In this respect, it should be mentioned 
that despite the strong increase in intestinal LDLr expres-
sion, the cholesterol concentrations in the serum and within 
the enterocyte did not change. Also, how these results com-
pare to the human situation warrants further study.
The ratio of cholestanol to cholesterol has been used 
to estimate intestinal cholesterol absorption. Though con-
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Fig. 7  Study 1: changes in the hepatic expression profile of genes 
involved in sterol metabolism. Values are expressed as means (n = 2 
or 3 each)
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associated with an increased risk for CVD [14, 15]. One 
advantage of this marker—in contrast to, for example, the 
campesterol/cholesterol ratio as marker for cholesterol 
absorption—is that it can be used when plant sterol con-
sumption is increased, as cholestanol cannot be formed 
from plant sterols. However, there is a clear lack of knowl-
edge regarding cholestanol metabolism. Serum cholestanol 
originates from dietary intake, as well as from bacterial for-
mation [32]. In our study, serum cholestanol concentrations 
largely followed over time the same pattern as observed 
for cholesterol, which supports the finding of Miettinen 
et al. [32] that serum cholesterol and cholestanol correlate 
positively in humans. However, from our data, it cannot 
be concluded whether or not cholestanol is a valid marker 
to measure intestinal cholesterol absorption, as this latter 
parameter was not measured in our study.
In summary, we have demonstrated that orally applied 
plant stanols had a fast appearance within the enterocytes, 
and in addition were rapidly taken up into the liver. This rapid 
hepatic appearance could not be observed in the lymph-cannu-
lated mice, suggesting a lymph-dependent route of entrance. 



































































































































Fig. 8  Study 1: time kinetics of cholesteranol levels in the serum (a, a′), the liver (b, b′) and the duodenum (c, c′) at different time points, 
expressed as absolute value (a–c) and as a ratio to cholesterol (a′–c′). Values are expressed as means (n = 2 or 3 each)
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genes involved in sterol metabolism were opposite to those of 
the intestines, indicating that acute effects of plant stanols are 
tissue specific. Finally, in the acute condition, intestinal LDLr 
and PCSK9 expression were strongly increased, for which 
we do not yet oversee the role in the changes in cholesterol 
metabolism towards longer-term interventions, but this cer-
tainly demands further attention in future studies.
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